• 1
    Sauaia A, Moore FA, Moore EE, Moser KS, Brennan R, Read RA, Pons PT. Epidemiology of trauma deaths: a reassessment. J Trauma 1995; 38: 18593.
  • 2
    Cales RH, Trunkey DD. Preventable trauma deaths. A review of trauma care systems development. JAMA 1985; 254: 105963.
  • 3
    Bellamy RF, Maningas PA, Vayer JS. Epidemiology of trauma: military experience. Ann Emerg Med 1986; 15: 13848.
  • 4
    Kelly JF, Ritenour AE, McLaughlin DF, Bagg KA, Apodaca AN, Mallak CT, Pearse L, Lawnick MM, Champion HR, Wade CE, Holcomb JB. Injury severity and causes of death from Operation Iraqi Freedom and Operation Enduring Freedom: 2003–2004 versus 2006. J Trauma 2008; 64: S216; discussion S26–7.
  • 5
    Holcomb JB, McMullin NR, Pearse L, Caruso J, Wade CE, Oetjen-Gerdes L, Champion HR, Lawnick M, Farr W, Rodriguez S, Butler FK. Causes of death in U.S. Special Operations Forces in the global war on terrorism: 2001–2004. Ann Surg 2007; 245: 98691.
  • 6
    Boffard KD, Riou B, Warren B, Choong PI, Rizoli S, Rossaint R, Axelsen M, Kluger Y. Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma 2005; 59: 815; discussion 15–18.
  • 7
    Johansson PI. Off-label use of recombinant factor VIIa for treatment of haemorrhage: results from randomized clinical trials. Vox Sang 2008; 95: 17.
  • 8
    Mannucci PM, Levi M. Prevention and treatment of major blood loss. N Engl J Med 2007; 356: 230111.
  • 9
    Coats T, Roberts I, Shakur H. Antifibrinolytic Drugs for Acute Traumatic Injury (Cochrane Review). Chichester, UK: Wiley, 2004.
  • 10
    Bode AP, Fischer TH. Lyophilized platelets: fifty years in the making. Artif Cells Blood Substit Immobil Biotechnol 2007; 35: 12533.
  • 11
    Flosdorf EW, Mudd S. Procedure and apparatus for preservation in ‘Lyophile’ form of serum and other biological substances. J Immunol 1935; 29: 389425.
  • 12
    Read MS, Reddick RL, Bode AP, Bellinger DA, Nichols TC, Taylor K, Smith SV, McMahon DK, Griggs TR, Brinkhous KM. Preservation of hemostatic and structural properties of rehydrated lyophilized platelets: potential for long-term storage of dried platelets for transfusion. Proc Natl Acad Sci USA 1995; 92: 397401.
  • 13
    Read MS, Bode AP. Platelet storage: efforts to extend the shelf life of platelet concentrates. Mol Med Today 1995; 1: 3228.
  • 14
    Fischer TH, Merricks EP, Russell KE, Raymer RA, White GC, Bode AP, Nichols TC, Read MS. Intracellular function in rehydrated lyophilized platelets. Br J Haematol 2000; 111: 16774.
  • 15
    Bode AP, Read MS, Reddick RL. Activation and adherence of lyophilized human platelets on canine vessel strips in the Baumgartner perfusion chamber. J Lab Clin Med 1999; 133: 20011.
  • 16
    Read MS, Khandelwal G, Miller RS, Taylor KK, Bode AP, Nichols TC, Reddick RL, Griggs TR. Rehydrated lyophilized platelets: a proposed mechanism contributing to the hemostatic action. Blood 1995; 86: 907a.
  • 17
    Arnaud F, Handrigan M, Hammett M, Philbin N, Rice J, Dong F, Pearce LB, McCarron R, Freilich D. Coagulation patterns following haemoglobin-based oxygen carrier resuscitation in severe uncontrolled haemorrhagic shock in swine. Transfus Med 2006; 16: 290302.
  • 18
    Brinkhous KM, Read MS. Preservation of platelet receptors for platelet aggregating factor/von Willebrand factor by air drying, freezing, or lyophilization: new stable platelet preparations for von Willebrand factor assays. Thromb Res 1978; 13: 5917.
  • 19
    Brecher ME, Hay SN. Bacterial contamination of blood components. Clin Microbiol Rev 2005; 18: 195204.
  • 20
    Bode AP, Read MS. Lyophilized platelets: continued development. Transfus Sci 2000; 22: 99105.
  • 21
    Cauwenberghs S, Van Pampus E, Curvers J, Akkerman JW, Heemskerk JW. Hemostatic and signaling functions of transfused platelets. Transfus Med Rev 2007; 21: 28794.
  • 22
    Mackman N. Triggers, targets and treatments for thrombosis. Nature 2008; 451: 91418.
  • 23
    Ruggeri ZM, Mendolicchio GL. Adhesion mechanisms in platelet function. Circ Res 2007; 100: 167385.
  • 24
    Sakariassen KS, Bolhuis PA, Sixma JJ. Human blood platelet adhesion to artery subendothelium is mediated by factor VIII–Von Willebrand factor bound to the subendothelium. Nature 1979; 279: 6368.
  • 25
    Jackson SP. The growing complexity of platelet aggregation. Blood 2007; 109: 508795.
  • 26
    Savage B, Almus-Jacobs F, Ruggeri ZM. Specific synergy of multiple substrate–receptor interactions in platelet thrombus formation under flow. Cell 1998; 94: 65766.
  • 27
    Goto S, Ikeda Y, Saldivar E, Ruggeri ZM. Distinct mechanisms of platelet aggregation as a consequence of different shearing flow conditions. J Clin Invest 1998; 101: 47986.
  • 28
    Sanders WEJ, Khandelwal G, Bellinger DA, Bode AP, Read MS. Fibrinogen binding to rehydrated lyophilized platelet surface GPIIbIIIa: normal clot formation and TPA lysis. Blood 1996; 88: 30a.
  • 29
    Fischer TH, Merricks EP, Bode AP, Bellinger DA, Russell K, Reddick R, Sanders WE, Nichols TC, Read MS. Thrombus formation with rehydrated, lyophilized platelets. Hematology 2002; 7: 35969.
  • 30
    Fischer TH, Bode AP, Parker BR, Russell KE, Bender DE, Ramer JK, Read MS. Primary and secondary hemostatic functionalities of rehydrated, lyophilized platelets. Transfusion 2006; 46: 194350.
  • 31
    Kiraly LN, Differding JA, Enomoto TM, Sawai RS, Muller PJ, Diggs B, Tieu BH, Englehart MS, Underwood S, Wiesberg TT, Schreiber MA. Resuscitation with normal saline (NS) vs. lactated Ringers (LR) modulates hypercoagulability and leads to increased blood loss in an uncontrolled hemorrhagic shock swine model. J Trauma 2006; 61: 5764; discussion 64–5.
  • 32
    Owings JT, Bagley M, Gosselin R, Romac D, Disbrow E. Effect of critical injury on plasma antithrombin activity: low antithrombin levels are associated with thromboembolic complications. J Trauma 1996; 41: 396405. .
  • 33
    Engelman DT, Gabram SG, Allen L, Ens GE, Jacobs LM. Hypercoagulability following multiple trauma. World J Surg 1996; 20: 510.
  • 34
    Bode AP, Blajchman M, Bardossy L, Read MS. Hemostatic properties of human lyophilized platelets in a thrombocytopenic rabbit model and a simulated bleeding time device. Blood 1994; 84: 464a.
  • 35
    Valeri CR, MacGregor H, Barnard MR, Summaria L, Michelson AD, Ragno G. Survival of baboon biotin-X-N-hydroxysuccinimide and (111)In-oxine-labelled autologous fresh and lyophilized reconstituted platelets. Vox Sang 2005; 88: 1229.
  • 36
    Bach FH, Robson SC, Winkler H, Ferran C, Stuhlmeier KM, Wrighton CJ, Hancock WW. Barriers to xenotransplantation. Nat Med 1995; 1: 86973.
  • 37
    Pareti FI, Mazzucato M, Bottini E, Mannucci PM. Interaction of porcine von Willebrand factor with the platelet glycoproteins Ib and IIb/IIIa complex. Br J Haematol 1992; 82: 816.
  • 38
    Mazzucato M, De Marco L, Pradella P, Masotti A, Pareti FI. Porcine von Willebrand factor binding to human platelet GPIb induces transmembrane calcium influx. Thromb Haemost 1996; 75: 65560.
  • 39
    Schulte Am Esch J II, Robson SC, Knoefel WT, Hosch SB, Rogiers X. O-linked glycosylation and functional incompatibility of porcine von Willebrand factor for human platelet GPIb receptors. Xenotransplantation 2005; 12: 307.
  • 40
    Gaca JG, Lesher A, Aksoy O, Ruggeri ZM, Parker W, Davis RD. The role of the porcine von Willebrand factor: baboon platelet interactions in pulmonary xenotransplantation. Transplantation 2002; 74: 1596603.
  • 41
    Luddington RJ. Thrombelastography/thromboelastometry. Clin Lab Haematol 2005; 27: 8190.